NCT02887833 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Delaney A, Fleetwood-Walker SM, Colvin LA, Fallon M
Translational medicine: cancer pain mechanisms and management. Br J Anaesth. 2008 Jul;101(1):87-94. doi: 10.1093/bja/aen100. Epub 2008 May 19. Review.
Laird BJ, Walley J, Murray GD, Clausen E, Colvin LA, Fallon MT
Characterization of cancer-induced bone pain: an exploratory study. Support Care Cancer. 2011 Sep;19(9):1393-401. doi: 10.1007/s00520-010-0961-3. Epub 2010 Aug 1.
Parker RA, Sande TA, Laird B, Hoskin P, Fallon M, Colvin L
Bayesian methods in palliative care research: cancer-induced bone pain. BMJ Support Palliat Care. 2020 Mar 5. pii: bmjspcare-2019-002160. doi: 10.1136/bmjspcare-2019-002160. [Epub ahead of print]

An Exploratory Study to Develop and Evaluate a Simple Bedside Tool for Community Use to Identify Who is Most Likely to Benefit From Palliative Radiotherapy for Cancer Induced Bone Pain: Thermal Testing in Bone Pain (TiBoP)

Details for clinical trial NCT02887833

Clinical trial NCT02887833 - References